Regulated genes by stimulation of chondrocytes with 1L-1beta

摘要

The present invention refers to the novel use of osteopontin, calnexin and TSG-6 gene product in the diagnosis, prophylaxis or therapy of IL-1 beta mediated diseases of connective tissues and to novel genes induced or repressed by stimulation of chondrocytes with IL-1 beta and their use in the diagnosis, prophylaxis or therapy of IL-1 beta mediated diseases of connective tissues.